Moderna-Vaccine_Study_Update_73164.jpg - Higher Ground Times

A sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Moderna shares slipped Tuesday, April 11, 2023, after the COVID-19 vaccine developer said its potential flu vaccine needs more study in a late-stage clinical trial. (AP Photo/Bill Sikes) **FILE**

Featured Photo Galleries

German authorities received tipoffs last year about the suspect in Christmas market attack

Man accused in UnitedHealthcare CEO killing faces federal charge, eligible for death penalty

Invasive 'murder hornets' are wiped out in the U.S., officials say

Oldest known stone tablet inscribed with the Ten Commandments sells for over $5M

Christmas at the White House

Commanders outlast Saints 20-19

3,700 people return to Malibu homes as weather conditions improve and help firefighters battle blaze

Trump Transition: Here are the people Trump has picked for key positions so far

President-elect Donald Trump has announced a flurry of picks for his incoming administration. Get full coverage of the Trump transition from The Washingon Times.

A wildfire in Malibu prompts evacuations as it burns near Pepperdine University

Taylor Swift: 'The Eras Tour' coming to a close

Trump is in Paris for Notre Dame Cathedral's reopening and to meet with Macron

Notre Dame reopens its doors to Macron and other world leaders in a rare symbol of unity